|
|
Previous Article | Table of Contents | Next Article 
Blood, Vol. 92 No. 9 (November 1), 1998:
pp. 3268-3276
Accutin, a New Disintegrin, Inhibits Angiogenesis In Vitro and In
Vivo by Acting as Integrin v 3 Antagonist
and Inducing Apoptosis
Chia Hsin Yeh,
Hui-Chin Peng, and
Tur-Fu Huang
From the Department of Pharmacology, College of Medicine, National
Taiwan University, Taipei, Taiwan.
Endothelial integrins play an essential role in angiogenesis and
cell survival. Accutin, a new member of disintegrin family derived from
venom of Agkistrodon acutus, potently inhibited human platelet
aggregation caused by various agonists (eg, thrombin, collagen, and,
adenosine diphosphate [ADP]) through the blockade of
fibrinogen binding to platelet glycoprotein IIb/IIIa (ie, integrin IIb 3). In this report, we describe that
accutin specifically inhibited the binding of monoclonal antibody
(MoAb) 7E3, which recognizes integrin v 3,
to human umbilical vein endothelial cells (HUVECs), but not those of
other anti-integrin MoAbs such as 2 1,
3 1, and 5 1.
Moreover, accutin, but not the control peptide GRGES, dose-dependently
inhibited the 7E3 interaction with HUVECs. Both 7E3 and
GRGDS, but not GRGES or Integrelin, significantly blocked fluorescein
isothiocyanate-conjugated accutin binding to HUVEC. In functional
studies, accutin exhibited inhibitory effects on HUVEC adhesion to
immobilized fibrinogen, fibronectin and vitronectin, and the
capillary-like tube formation on Matrigel in a dose- and RGD-dependent
manner. In addition, it exhibited an effective antiangiogenic effect in
vivo when assayed by using the 10-day-old embryo chick CAM model.
Furthermore, it potently induced HUVEC apoptotic DNA fragmentation as
examined by electrophoretic and flow cytometric assays. In conclusion,
accutin inhibits angiogenesis in vivo and in vitro by blocking integrin
v 3 of endothelial cells and by inducing
apoptosis. The antiangiogenic activity of disintegrins might be
explored as the target of developing the potential antimetastatic
agents.
© 1998 by The American Society of Hematology.

CiteULike Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
I. Staniszewska, S. Zaveri, L. D. Valle, I. Oliva, V. L. Rothman, S. E. Croul, D. D. Roberts, D. F. Mosher, G. P. Tuszynski, and C. Marcinkiewicz
Interaction of {alpha}9{beta}1 Integrin With Thrombospondin-1 Promotes Angiogenesis
Circ. Res.,
May 11, 2007;
100(9):
1308 - 1316.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J Heidemann, D G Binion, W Domschke, and T Kucharzik
Antiangiogenic therapy in human gastrointestinal malignancies.
Gut,
October 1, 2006;
55(10):
1497 - 1511.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. S. Aguzzi, C. Giampietri, F. De Marchis, F. Padula, R. Gaeta, G. Ragone, M. C. Capogrossi, and A. Facchiano
RGDS peptide induces caspase 8 and caspase 9 activation in human endothelial cells
Blood,
June 1, 2004;
103(11):
4180 - 4187.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. R. Cominetti, C. H. B. Terruggi, O. H. P. Ramos, J. W. Fox, A. Mariano-Oliveira, M. S. De Freitas, C. C. Figueiredo, V. Morandi, and H. S. Selistre-de-Araujo
Alternagin-C, a Disintegrin-like Protein, Induces Vascular Endothelial Cell Growth Factor (VEGF) Expression and Endothelial Cell Proliferation in Vitro
J. Biol. Chem.,
April 30, 2004;
279(18):
18247 - 18255.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
V. Trochon-Joseph, D. Martel-Renoir, L. M. Mir, A. Thomaidis, P. Opolon, E. Connault, H. Li, C. Grenet, F. Fauvel-Lafeve, J. Soria, et al.
Evidence of Antiangiogenic and Antimetastatic Activities of the Recombinant Disintegrin Domain of Metargidin
Cancer Res.,
March 15, 2004;
64(6):
2062 - 2069.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C.-H. Chung, W.-B. Wu, and T.-F. Huang
Aggretin, a snake venom-derived endothelial integrin {alpha}2{beta}1 agonist, induces angiogenesis via expression of vascular endothelial growth factor
Blood,
March 15, 2004;
103(6):
2105 - 2113.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Hagedorn, L. Zilberberg, J. Wilting, X. Canron, G. Carrabba, C. Giussani, M. Pluderi, L. Bello, and A. Bikfalvi
Domain Swapping in a COOH-terminal Fragment of Platelet Factor 4 Generates Potent Angiogenesis Inhibitors
Cancer Res.,
December 1, 2002;
62(23):
6884 - 6890.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. McCaig, C. M. Perks, and J. M. P. Holly
Intrinsic actions of IGFBP-3 and IGFBP-5 on Hs578T breast cancer epithelial cells: inhibition or accentuation of attachment and survival is dependent upon the presence of fibronectin
J. Cell Sci.,
November 15, 2002;
115(22):
4293 - 4303.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. Shizukuda and P. M. Buttrick
Oxygen free radicals and heart failure: new insight into an old question
Am J Physiol Lung Cell Mol Physiol,
August 1, 2002;
283(2):
L237 - L238.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C.-H. Yeh, H.-C. Peng, R.-S. Yang, and T.-F. Huang
Rhodostomin, A Snake Venom Disintegrin, Inhibits Angiogenesis Elicited by Basic Fibroblast Growth Factor and Suppresses Tumor Growth by A Selective alpha vbeta 3 Blockade of Endothelial Cells
Mol. Pharmacol.,
April 16, 2001;
59(5):
1333 - 1342.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
M. Strasly, F. Cavallo, M. Geuna, S. Mitola, M. P. Colombo, G. Forni, and F. Bussolino
IL-12 Inhibition of Endothelial Cell Functions and Angiogenesis Depends on Lymphocyte-Endothelial Cell Cross-Talk
J. Immunol.,
March 15, 2001;
166(6):
3890 - 3899.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
I. Wierzbicka-Patynowski, S. Niewiarowski, C. Marcinkiewicz, J. J. Calvete, M. M. Marcinkiewicz, and M. A. McLane
Structural Requirements of Echistatin for the Recognition of alpha vbeta 3 and alpha 5beta 1 Integrins
J. Biol. Chem.,
December 31, 1999;
274(53):
37809 - 37814.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. T. Nurden, C. Poujol, C. Durrieu-Jais, and P. Nurden
Platelet Glycoprotein IIb/IIIa Inhibitors : Basic and Clinical Aspects
Arterioscler Thromb Vasc Biol,
December 1, 1999;
19(12):
2835 - 2840.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
I.-C. Kang, Y.-D. Lee, and D.-S. Kim
A Novel Disintegrin Salmosin Inhibits Tumor Angiogenesis
Cancer Res.,
August 1, 1999;
59(15):
3754 - 3760.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C.-H. Yeh, W.-C. Wang, T.-T. Hsieh, and T.-F. Huang
Agkistin, a Snake Venom-derived Glycoprotein Ib Antagonist, Disrupts von Willebrand Factor-Endothelial Cell Interaction and Inhibits Angiogenesis
J. Biol. Chem.,
June 16, 2000;
275(25):
18615 - 18618.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|
|